Vanguard Global Advisers’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.6M Sell
177,104
-4,878
-3% -$1.28M 0.02% 413
2026
Q1
$48.6M Buy
+181,982
New +$49.3M 0.03% 403

Other funds holding LH

Vanguard Global Advisers's LH Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Labcorp (LH) stake by 2.7% in Q2 2026, selling an estimated $1.28M and leaving 177,104 shares worth $49.6M. The position accounts for 0.02% of the portfolio, ranked #413.

Vanguard Global Advisers first reported a position in LH in Q1 2026 and has held it in 2 quarters since. 1,005 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Vanguard Global Advisers held 177,104 shares of Labcorp worth $49.6M as of Q2 2026.
  • Vanguard Global Advisers sold 4,878 Labcorp shares in Q2 2026, an estimated $1.28M.
  • Labcorp made up 0.02% of Vanguard Global Advisers's portfolio in Q2 2026, its #413 holding.
  • Vanguard Global Advisers first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
  • 1,005 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.